Envoy Medical COCH Proceeds from debt financing, net of issuance costs
Proceeds from debt financing, net of issuance costs at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromDebtNetOfIssuanceCosts.
The official record: Envoy Medical’s 10-Q, filed July 31, 2025, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's proceeds from debt financing, net of issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's proceeds from debt financing, net of issuance costs?
- Envoy Medical (COCH) reported proceeds from debt financing, net of issuance costs of $200K in Q2 2025.
- What does proceeds from debt financing, net of issuance costs mean?
- Reflects the net cash inflows from debt financing activities after deducting direct costs associated with the issuance, such as underwriting fees and legal expenses. It measures the actual liquidity available to the company from new debt obligations, excluding the friction costs of the financing process.